908 Devices Inc. Common Stock (MASS)

FairStock Score: 56/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach 908 Devices as a small, specialized toolmaker. Its handheld mass spectrometry and FTIR devices serve niche safety and health markets, and customers likely value ruggedness and speed. But with 172 employees and fiscal 2025 revenue of $56.2 million (period ended 2025-12-31), scale is modest, and larger instrument makers could pressure it. The record is uneven: fiscal 2024 revenue was $47.7 million with a net loss of $72.2 million; fiscal 2025 revenue rose to $56.2 million and net income was $19.5 million, which is why FairStock labels it a TURNAROUND. Yet the latest filings show renewed losses: in fiscal Q1 2026 (quarter ended 2026-03-31), revenue was $13.4 million and net loss $12.0 million; in fiscal Q2 2026 (quarter ended 2026-06-30), revenue was $16.1 million and net loss $11.9 million. That suggests the fiscal 2025 profit may not be repeatable. Financial health is mixed: debt to equity is only 0.03, Altman Z-score 2.96, and Piotroski 6/9, but trailing free cash flow is just $615,000, a 0.1% FCF yield. At the 2026-10-13 close of $12.09, FairStock shows a negative P/E of -13.00, P/B of 3.37, ROE -24.95%, and ROCE -6.81%. The stock is near the high end of its 52-week range of $5.03 to $13.35 and carries a 56/100 FairStock score. I see a promising technology but no clear margin of safety until profits and cash flow become consistent.

In plain English: 908 Devices makes handheld instruments that identify unknown chemicals, gases, and vapors for health and safety work. Revenue has grown, but the company is losing money again in recent reported quarters, and its profits have swung sharply. At the latest close of $12.09, the market price looks expensive next to current losses and very small cash generation.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer